CoChat
Sign Up
Cited by 220Intracerebral and Subarachnoid Hemorrhage ResearchBarrier Structure and Function StudiesTraumatic Brain Injury and Neurovascular Disturbances

The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.

Vascular disruption and blood–brain barrier dysfunction in intracerebral hemorrhage

Open access
Keep, Richard F, Zhou, Ningna, Xiang, Jianming, Andjelkovic, Anuska V, Hua, Ya, Xi, Guohua·2014·Fluids and Barriers of the CNS
DOI 10.1186/2045-8118-11-18PMC PMC4130123
Open this paper in CoChat — free accountOpen PDF

Abstract

This article reviews current knowledge of the mechanisms underlying the initial hemorrhage and secondary blood-brain barrier (BBB) dysfunction in primary spontaneous intracerebral hemorrhage (ICH) in adults. Multiple etiologies are associated with ICH, for example, hypertension, Alzheimer's disease, vascular malformations and coagulopathies (genetic or drug-induced). After the initial bleed, there can be continued bleeding over the first 24 hours, so-called hematoma expansion, which is associated with adverse outcomes. A number of clinical trials are focused on trying to limit such expansion. Significant progress has been made on the causes of BBB dysfunction after ICH at the molecular and cell signaling level. Blood components (e.g. thrombin, hemoglobin, iron) and the inflammatory response to those components play a large role in ICH-induced BBB dysfunction. There are current clinical trials of minimally invasive hematoma removal and iron chelation which may limit such dysfunction. Understanding the mechanisms underlying the initial hemorrhage and secondary BBB dysfunction in ICH is vital for developing methods to prevent and treat this devastating form of stroke.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/2045-8118-11-18

Cites

145 of 145 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Photomicrographs showing both sides of serial coronal sections (thickness approximately 5 mm) containing hematoma (#) and edematous white matter (*) 24 hours after blood infusion in a pig brain frozen in situ. Perihematomal edema is present as blue-staining translucent regions in white matter adjacent to the hematoma. Evans blue staining is observed throughout the ipsilateral white matter and is indicative of increased BBB permeability and vasogenic edema development. Figure/legend reprinted with permission from Journal of Neurosurgery[11].
Figure 1 Photomicrographs showing both sides of serial coronal sections (thickness approximately 5 mm) containing hematoma (#) and edematous white matter (*) 24 hours after blood infusion in a pig brain frozen in situ. Perihematomal edema is present as blue-staining translucent regions in white matter adjacent to the hematoma. Evans blue staining is observed throughout the ipsilateral white matter and is indicative of increased BBB permeability and vasogenic edema development. Figure/legend reprinted with permission from Journal of Neurosurgery[11].CC BY · PubMed Central
Figure 2 Flair magnetic resonance imaging in a patient at day 1 after ICH. Note the marked edema (#) surrounding the hematoma (*).
Figure 2 Flair magnetic resonance imaging in a patient at day 1 after ICH. Note the marked edema (#) surrounding the hematoma (*).CC BY · PubMed Central
Figure 3 Hematoxylin & eosin staining of a section from the brain of a patient with cerebral cavernous malformation (type CCM3). Note the multiple blood vessels with little or no intervening parenchymal tissue. Scale bar = 200 μm.
Figure 3 Hematoxylin & eosin staining of a section from the brain of a patient with cerebral cavernous malformation (type CCM3). Note the multiple blood vessels with little or no intervening parenchymal tissue. Scale bar = 200 μm.CC BY · PubMed Central
Figure 4 The underlying cause of secondary BBB dysfunction appears to differ in ICH (A) from cerebral ischemia (B). In ICH, evidence indicates a major role for the presence of blood components in brain parenchyma activating a number of pathways (cell injury, receptor-mediated signaling and inflammation) leading to BBB dysfunction. In contrast, in cerebral ischemia, the initiating cause of injury is the lack of oxygen and glucose supply to the brain. Delayed restoration of blood flow can also induce BBB dysfunction (reperfusion injury). With ischemic injury, there are a number of factors that can enhance the BBB dysfunction. Thus, for example, hyperglycemia and tissue plasminogen activator (tPA) both can result in hemorrhage after reperfusion. Less is known about factors that enhance secondary BBB dysfunction in ICH.
Figure 4 The underlying cause of secondary BBB dysfunction appears to differ in ICH (A) from cerebral ischemia (B). In ICH, evidence indicates a major role for the presence of blood components in brain parenchyma activating a number of pathways (cell injury, receptor-mediated signaling and inflammation) leading to BBB dysfunction. In contrast, in cerebral ischemia, the initiating cause of injury is the lack of oxygen and glucose supply to the brain. Delayed restoration of blood flow can also induce BBB dysfunction (reperfusion injury). With ischemic injury, there are a number of factors that can enhance the BBB dysfunction. Thus, for example, hyperglycemia and tissue plasminogen activator (tPA) both can result in hemorrhage after reperfusion. Less is known about factors that enhance secondary BBB dysfunction in ICH.CC BY · PubMed Central
Figure 5 During hematoma resolution after ICH, there is phagocytosis of erythrocytes by invading macrophages/microglia. Hematoxylin & eosin stained section from a pig ICH model (described in [10]) at day 7 after blood injection. Note the phagocytes engulfing erythrocytes (*) and the production of hemosiderin, a breakdown product of hemoglobin (yellow staining).
Figure 5 During hematoma resolution after ICH, there is phagocytosis of erythrocytes by invading macrophages/microglia. Hematoxylin & eosin stained section from a pig ICH model (described in [10]) at day 7 after blood injection. Note the phagocytes engulfing erythrocytes (*) and the production of hemosiderin, a breakdown product of hemoglobin (yellow staining).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 144 references

Cited by

Sorted by citations

See all 220

Related

Metadata

Authors
Keep, R. F., Zhou, N., Xiang, J., Andjelkovic, A. V., Hua, Y., & Xi, G.
Affiliations
University of Michigan (US)
Corresponding author
Keep, Richard F
ORCID
Venue
Fluids and Barriers of the CNS
Publisher
Springer Science and Business Media LLC
Published
2014
Volume
11
Issue
1
Pages
18
ISSN
2045-8118 (ISSN-L)
DOI
10.1186/2045-8118-11-18
PMC
PMC4130123
OpenAlex
W2103156349
Cited by
220
References
144
Citations by year
2026: 22 · 2025: 20 · 2024: 17 · 2023: 19 · 2022: 23 · 2021: 18 · 2020: 29 · 2019: 17 · 2018: 9 · 2017: 24 · 2016: 12 · 2015: 9 · 2014: 1
FWCI
2.10
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Fluids and Barriers of the CNS (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Deep Blue (University of Michigan) (submittedVersion)
Funders
  • National Institutes of Health (NS073959, NS079157)
  • National Institute of Neurological Disorders and Stroke (R21NS075757, R01NS034709, R21NS084049, R01NS079157)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
Keywords
intracerebral hemorrhage, blood-brain barrier dysfunction, hematoma expansion, vascular disruption, thrombin, hemoglobin, iron, neuroinflammation, iron chelation, hematoma evacuation, hypertension, vascular malformations, coagulopathy, Alzheimer's disease, secondary hemorrhage

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review